LYNN CHEN: Open Payments
NPI 1538698691 · VERSAILLES, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,237 in 64 payments from 19 companies in 2025. Trend: 2023 $1,311 · 2024 $1,217 · 2025 $2,237
Food & beverage: $2,237
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $492 |
| ABBVIE INC. | 12 | $456 |
| Lilly USA, LLC | 5 | $188 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $171 |
| Gilead Sciences, Inc. | 3 | $151 |
| Phathom Pharmaceuticals, Inc. | 10 | $148 |
| Madrigal Pharmaceuticals | 2 | $133 |
| Novo Nordisk Inc | 1 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $96 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
Products named: TREMFYA, RINVOQ, OMVOH, SKYRIZI, XIFAXAN, VOQUEZNA, REZDIFFRA, Wegovy.
Industry payments across KY — which companies pay providers there.
